Chad Messer
Stock Analyst at Lake Street
(0.52)
# 3,964
Out of 4,931 analysts
25
Total ratings
32%
Success rate
-23.41%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Chad Messer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COYA Coya Therapeutics | Initiates: Buy | $16 | $6.46 | +147.68% | 1 | Jul 9, 2025 | |
| BOLT Bolt Biotherapeutics | Initiates: Buy | $80 | $5.60 | +1,328.57% | 1 | May 20, 2025 | |
| LTRN Lantern Pharma | Initiates: Buy | $25 | $5.20 | +380.77% | 1 | Apr 2, 2025 | |
| IMNM Immunome | Initiates: Buy | $23 | $10.66 | +115.76% | 1 | Apr 2, 2025 | |
| OSTX OS Therapies | Initiates: Buy | $19 | $1.76 | +979.55% | 1 | Apr 2, 2025 | |
| ESPR Esperion Therapeutics | Maintains: Strong Buy | $134 → $114 | $1.87 | +6,012.60% | 3 | Aug 3, 2021 | |
| CELC Celcuity | Initiates: Buy | $50 | $44.20 | +13.12% | 1 | Jul 27, 2021 | |
| CYTK Cytokinetics | Maintains: Buy | $33 → $48 | $35.14 | +36.60% | 2 | Jul 19, 2021 | |
| EXEL Exelixis | Maintains: Buy | $33 → $30 | $37.23 | -19.42% | 3 | Jun 28, 2021 | |
| RNA Avidity Biosciences | Initiates: Buy | $50 | $46.28 | +8.04% | 1 | Jun 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $29 | $9.83 | +195.02% | 2 | May 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.63 | +513.50% | 1 | Apr 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $95 → $86 | $40.52 | +112.27% | 2 | Mar 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $3.83 | +1,858.22% | 1 | Mar 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $44 | $10.34 | +325.53% | 2 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $182 → $166 | $18.20 | +812.09% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $18 | $3.01 | +499.00% | 1 | May 5, 2020 |
Coya Therapeutics
Jul 9, 2025
Initiates: Buy
Price Target: $16
Current: $6.46
Upside: +147.68%
Bolt Biotherapeutics
May 20, 2025
Initiates: Buy
Price Target: $80
Current: $5.60
Upside: +1,328.57%
Lantern Pharma
Apr 2, 2025
Initiates: Buy
Price Target: $25
Current: $5.20
Upside: +380.77%
Immunome
Apr 2, 2025
Initiates: Buy
Price Target: $23
Current: $10.66
Upside: +115.76%
OS Therapies
Apr 2, 2025
Initiates: Buy
Price Target: $19
Current: $1.76
Upside: +979.55%
Esperion Therapeutics
Aug 3, 2021
Maintains: Strong Buy
Price Target: $134 → $114
Current: $1.87
Upside: +6,012.60%
Celcuity
Jul 27, 2021
Initiates: Buy
Price Target: $50
Current: $44.20
Upside: +13.12%
Cytokinetics
Jul 19, 2021
Maintains: Buy
Price Target: $33 → $48
Current: $35.14
Upside: +36.60%
Exelixis
Jun 28, 2021
Maintains: Buy
Price Target: $33 → $30
Current: $37.23
Upside: -19.42%
Avidity Biosciences
Jun 17, 2021
Initiates: Buy
Price Target: $50
Current: $46.28
Upside: +8.04%
May 14, 2021
Maintains: Buy
Price Target: $31 → $29
Current: $9.83
Upside: +195.02%
Apr 5, 2021
Initiates: Buy
Price Target: $10
Current: $1.63
Upside: +513.50%
Mar 23, 2021
Maintains: Buy
Price Target: $95 → $86
Current: $40.52
Upside: +112.27%
Mar 15, 2021
Initiates: Buy
Price Target: $75
Current: $3.83
Upside: +1,858.22%
Jan 8, 2021
Maintains: Buy
Price Target: $35 → $44
Current: $10.34
Upside: +325.53%
Jan 8, 2021
Maintains: Buy
Price Target: $182 → $166
Current: $18.20
Upside: +812.09%
May 5, 2020
Maintains: Buy
Price Target: $15 → $18
Current: $3.01
Upside: +499.00%